For: | Wang LJ, Yao X, Qi Q, Qin JP. Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt. World J Gastrointest Surg 2023; 15(8): 1564-1573 [PMID: 37701697 DOI: 10.4240/wjgs.v15.i8.1564] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v15/i8/1564.htm |
Number | Citing Articles |
1 |
Xiaowei Xu, Yun Yang, Xinru Tan, Ziyang Zhang, Boxiang Wang, Xiaojie Yang, Chujun Weng, Rongwen Yu, Qi Zhao, Shichao Quan. Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment. Computational and Structural Biotechnology Journal 2024; 24: 493 doi: 10.1016/j.csbj.2024.07.008
|
2 |
Xiaotong Xu, Tong Zhu, Changyou Jing, Minjie Jiang, Yunlai Fu, Fang Xie, Qinghua Meng, Jianjun Li. Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1423780
|
3 |
Sara Malik, Hassan Aziz, Nadeem Ullah, Anjum Raza, Huzaifa Nazir Siddiqui, Romaisa Khalid. Effectiveness and Clinical Outcomes of Long-Term Rifaximin in Cirrhotic Patients with Hepatic Encephalopathy. Pakistan Journal of Health Sciences 2024; : 300 doi: 10.54393/pjhs.v5i12.1958
|